Skip to main content
. 2022 Jan 28;113(3):986–1001. doi: 10.1111/cas.15268

FIGURE 1.

FIGURE 1

Serine/threonine kinase 16 (STK16) expression is associated with lung adenocarcinoma (LUAD) progression and survival rate. STK16 mRNA expression in (A) TCGA database and (C) tumor and paired normal tissues from 20 LUAD patients in hospital cohort 1. (D) immunohistochemistry (IHC) analysis for STK16 protein expression in tumor and normal tissues from LUAD patients in hospital cohort 2. Scale bars: 100 μm. The overall survival of LUAD patients in (B) Kaplan‐Meier plotter database and (E) hospital cohort 2. ***P < .001 compared with N